泰格医药投出一家创新药IPO，恒瑞前员工创办，估值39亿

Core Viewpoint - The article discusses the IPO of an innovative drug company founded by a former employee of Heng Rui, with a valuation of 3.9 billion [1] Group 1 - The innovative drug company is backed by Tai Ge Pharmaceutical, indicating strong industry support [1] - The founder's previous experience at Heng Rui suggests a solid background in the pharmaceutical sector, which may enhance investor confidence [1] - The valuation of 3.9 billion highlights the potential market interest and growth prospects for the company [1]